Principal Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$64.7M Sell
123,249
-6,376
-5% -$3.35M 0.03% 384
2025
Q1
$82.2M Sell
129,625
-865
-0.7% -$549K 0.05% 316
2024
Q4
$93M Sell
130,490
-42,602
-25% -$30.3M 0.05% 305
2024
Q3
$182M Buy
173,092
+2,828
+2% +$2.97M 0.1% 182
2024
Q2
$179M Buy
170,264
+1,852
+1% +$1.95M 0.11% 172
2024
Q1
$162M Buy
168,412
+37,685
+29% +$36.3M 0.1% 184
2023
Q4
$115M Sell
130,727
-628
-0.5% -$552K 0.07% 224
2023
Q3
$108M Sell
131,355
-1,672
-1% -$1.38M 0.08% 214
2023
Q2
$95.6M Sell
133,027
-3,241
-2% -$2.33M 0.07% 254
2023
Q1
$112M Buy
136,268
+1,614
+1% +$1.33M 0.08% 223
2022
Q4
$97.2M Sell
134,654
-9,777
-7% -$7.05M 0.07% 238
2022
Q3
$99.5M Buy
144,431
+14,963
+12% +$10.3M 0.08% 218
2022
Q2
$76.5M Buy
129,468
+3,323
+3% +$1.96M 0.06% 285
2022
Q1
$88.1M Buy
126,145
+264
+0.2% +$184K 0.06% 283
2021
Q4
$79.5M Sell
125,881
-2,415
-2% -$1.53M 0.05% 310
2021
Q3
$77.6M Buy
128,296
+2,682
+2% +$1.62M 0.05% 302
2021
Q2
$70.2M Sell
125,614
-6,296
-5% -$3.52M 0.05% 340
2021
Q1
$62.4M Sell
131,910
-9,970
-7% -$4.72M 0.04% 357
2020
Q4
$68.5M Sell
141,880
-6,275
-4% -$3.03M 0.05% 319
2020
Q3
$82.9M Sell
148,155
-3,617
-2% -$2.02M 0.07% 265
2020
Q2
$94.7M Buy
151,772
+34,093
+29% +$21.3M 0.08% 251
2020
Q1
$57.5M Buy
117,679
+6,645
+6% +$3.24M 0.06% 296
2019
Q4
$41.7M Sell
111,034
-3,453
-3% -$1.3M 0.03% 439
2019
Q3
$31.8M Buy
114,487
+1,639
+1% +$455K 0.03% 522
2019
Q2
$35.3M Sell
112,848
-2,952
-3% -$924K 0.03% 483
2019
Q1
$47.5M Buy
115,800
+712
+0.6% +$292K 0.04% 398
2018
Q4
$43M Sell
115,088
-1,543
-1% -$576K 0.05% 394
2018
Q3
$47.1M Buy
116,631
+2,315
+2% +$935K 0.04% 437
2018
Q2
$39.4M Buy
114,316
+442
+0.4% +$152K 0.04% 468
2018
Q1
$39.2M Sell
113,874
-295
-0.3% -$102K 0.04% 468
2017
Q4
$42.9M Buy
114,169
+2,087
+2% +$785K 0.04% 460
2017
Q3
$50.1M Sell
112,082
-3,119
-3% -$1.39M 0.05% 414
2017
Q2
$56.6M Buy
115,201
+2,646
+2% +$1.3M 0.06% 376
2017
Q1
$43.6M Buy
112,555
+2,263
+2% +$877K 0.05% 371
2016
Q4
$40.5M Sell
110,292
-404
-0.4% -$148K 0.05% 375
2016
Q3
$44.5M Sell
110,696
-1,275
-1% -$513K 0.06% 319
2016
Q2
$39.1M Buy
111,971
+2,350
+2% +$821K 0.05% 323
2016
Q1
$39.5M Buy
109,621
+3,038
+3% +$1.1M 0.06% 317
2015
Q4
$57.9M Buy
106,583
+2,198
+2% +$1.19M 0.09% 246
2015
Q3
$48.6M Buy
104,385
+3,236
+3% +$1.51M 0.08% 273
2015
Q2
$51.6M Buy
101,149
+4,346
+4% +$2.22M 0.08% 271
2015
Q1
$43.7M Buy
96,803
+2,007
+2% +$906K 0.07% 301
2014
Q4
$38.9M Buy
94,796
+2,855
+3% +$1.17M 0.06% 313
2014
Q3
$33.1M Sell
91,941
-6,359
-6% -$2.29M 0.06% 333
2014
Q2
$27.8M Sell
98,300
-965
-1% -$273K 0.05% 391
2014
Q1
$29.8M Buy
99,265
+2,189
+2% +$657K 0.05% 370
2013
Q4
$26.7M Buy
97,076
+758
+0.8% +$209K 0.05% 394
2013
Q3
$30.1M Buy
96,318
+2,806
+3% +$878K 0.06% 338
2013
Q2
$21M Buy
+93,512
New +$21M 0.05% 425